Correlation Between Boeing and ADMA Biologics
Can any of the company-specific risk be diversified away by investing in both Boeing and ADMA Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boeing and ADMA Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Boeing and ADMA Biologics, you can compare the effects of market volatilities on Boeing and ADMA Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boeing with a short position of ADMA Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boeing and ADMA Biologics.
Diversification Opportunities for Boeing and ADMA Biologics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Boeing and ADMA is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding The Boeing and ADMA Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADMA Biologics and Boeing is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Boeing are associated (or correlated) with ADMA Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADMA Biologics has no effect on the direction of Boeing i.e., Boeing and ADMA Biologics go up and down completely randomly.
Pair Corralation between Boeing and ADMA Biologics
Allowing for the 90-day total investment horizon The Boeing is expected to under-perform the ADMA Biologics. But the stock apears to be less risky and, when comparing its historical volatility, The Boeing is 2.63 times less risky than ADMA Biologics. The stock trades about -0.01 of its potential returns per unit of risk. The ADMA Biologics is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 1,643 in ADMA Biologics on August 27, 2024 and sell it today you would earn a total of 475.00 from holding ADMA Biologics or generate 28.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
The Boeing vs. ADMA Biologics
Performance |
| Timeline |
| Boeing |
| ADMA Biologics |
Boeing and ADMA Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Boeing and ADMA Biologics
The main advantage of trading using opposite Boeing and ADMA Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boeing position performs unexpectedly, ADMA Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADMA Biologics will offset losses from the drop in ADMA Biologics' long position.The idea behind The Boeing and ADMA Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| ADMA Biologics vs. Atara Biotherapeutics | ADMA Biologics vs. Fate Therapeutics | ADMA Biologics vs. Sana Biotechnology | ADMA Biologics vs. Caribou Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |